The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global atherectomy devices market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Atherectomy devices refer to various minimally invasive (MI) instruments used for peripheral vascular intervention procedures. They are designed to re-establish blood flow in the arteries by drilling, grinding, shaving, sanding and vaporizing plaque, calcifying lesions and excessive cellular material. Some of the commonly used atherectomy devices include direction, orbital, photo-ablative, rotational and support atherectomy devices. The devices consist of a rotating blade inside a tubular catheter attached to a battery-operated motor that spins the cutter and removes the plaque or calcified lesion. As a result, atherectomy devices find extensive applications in hospitals, surgical centers and ambulatory care centers.
The increasing prevalence of peripheral artery disease (PAD), atherosclerosis, diabetes and obesity, along with the rising geriatric population across the globe, represent as the key factors driving the growth of the market. Furthermore, the growing preference for MI atherectomy surgical procedures among both patients and healthcare providers is creating a positive outlook for the market. These devices reduce the risks of infections, cause minimal pain and trauma during the surgery and facilitate faster recovery of the patient. Additionally, various product innovations, such as the development of drug-coated balloons (DCB), are acting as other growth-inducing factors. DCBs are used in place of permanent implants with directional atherectomy and anti-restenosis therapy (DAART) to deliver anti-proliferative drugs and treat lesions with severe calcifications. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global atherectomy devices market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product, application and end user.
Breakup by Product:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Avinger, B. Braun Group, Biomerics, Biotronik, Boston Scientific, C.R. Bard (BD), Cardinal Health, Koninklijke Philips, Medtronic, Minnetronix Inc., Straub Medical AG (BD) and Terumo Corporation.
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Abbott Laboratories, Avinger, B. Braun Group, Biomerics, Biotronik, Boston Scientific, C.R. Bard (BD), Cardinal Health, Koninklijke Philips, Medtronic, Minnetronix Inc., Straub Medical AG (BD) and Terumo Corporation|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
According to the estimates by IMARC Group, the global atherectomy devices market is expected to grow at a CAGR of around 5% during 2021-2026.
The rising adoption of atherectomy devices for treating peripheral artery diseases (PADs) and coronary artery diseases (CADs) represents one of the key drivers for the global atherectomy devices market.
The growing integration of directional atherectomy with anti-restenosis therapy (DAART) to improve the patency in long lesions and lesions with severe calcifications, represents one of the major trends in the global atherectomy devices market.
Sudden outbreak of the COVID-19 pandemic had led to the cancellation or postponement of several elective cardiovascular surgeries to reduce the risk of coronavirus infection upon hospital visits.
On the basis of the product, the market has been classified into directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, and support devices. Among these, directional atherectomy devices hold the majority of market share.
On the basis of the application, the market has been classified into peripheral vascular, cardiovascular, and neurovascular. Among these, peripheral vascular represents the largest segment.
On the basis of the end user, the market has been bifurcated into hospitals, ambulatory surgery centers, and research laboratories and academic institutes. Among these, hospitals dominate the market share.
Region-wise, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America dominates the global market.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at